We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTLF icon
3676
FitLife Brands
FTLF
$103M
$19.1K ﹤0.01%
+2,002
New +$20.5K
RBBN icon
3677
Ribbon Communications
RBBN
$381M
$19.1K ﹤0.01%
6,589
+25
+0.4% +$56
FSK icon
3678
FS KKR Capital
FSK
$3.46B
$19.1K ﹤0.01%
954
-5,311
-85% -$104K
BVS icon
3679
Bioventus
BVS
$1.16B
$19K ﹤0.01%
3,613
-19,478
-84% -$77.1K
JANX icon
3680
Janux Therapeutics
JANX
$968M
$19K ﹤0.01%
1,768
+460
+35% +$3.98K
SGC icon
3681
Superior Group of Companies
SGC
$210M
$18.9K ﹤0.01%
+1,399
New +$14.6K
GUNR icon
3682
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.05B
$18.9K ﹤0.01%
461
-11,521
-96% -$459K
EDC icon
3683
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$169M
$18.8K ﹤0.01%
618
+588
+1,960% +$15.4K
RSKD icon
3684
Riskified
RSKD
$850M
$18.8K ﹤0.01%
4,015
-11,693
-74% -$47.9K
QURE icon
3685
uniQure
QURE
$3.25B
$18.7K ﹤0.01%
2,763
-12,205
-82% -$80.7K
UGP icon
3686
Ultrapar
UGP
$6.41B
$18.7K ﹤0.01%
3,450
-6,726
-66% -$31K
MPB icon
3687
Mid Penn Bancorp
MPB
$971M
$18.7K ﹤0.01%
769
-2,990
-80% -$63.6K
LNZA icon
3688
LanzaTech
LNZA
$67.1M
$18.7K ﹤0.01%
37
-14
-27% -$6.16K
SMBK icon
3689
SmartFinancial
SMBK
$903M
$18.7K ﹤0.01%
762
-2,430
-76% -$53.8K
JMSB icon
3690
John Marshall Bancorp
JMSB
$331M
$18.7K ﹤0.01%
827
-35
-4% -$673
MVBF icon
3691
MVB Financial
MVBF
$394M
$18.6K ﹤0.01%
826
+250
+43% +$5.29K
SUZ icon
3692
Suzano
SUZ
$9.95B
$18.6K ﹤0.01%
+1,640
New +$17.7K
GTHX
3693
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$18.6K ﹤0.01%
6,100
-1,995
-25% -$3.75K
DBEF icon
3694
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.43B
$18.6K ﹤0.01%
503
-774
-61% -$27.4K
FAT
3695
DELISTED
FAT Brands
FAT
$18.6K ﹤0.01%
5,502
+3,529
+179% +$12.2K
ALCO icon
3696
Alico
ALCO
$304M
$18.6K ﹤0.01%
639
+94
+17% +$2.52K
CRH icon
3697
CRH
CRH
$64.4B
$18.5K ﹤0.01%
268
-4,554
-94% -$275K
NPWR icon
3698
NET Power
NPWR
$146M
$18.5K ﹤0.01%
+1,835
New +$22K
BKYI
3699
BIO-key International
BKYI
$3.27M
$18.5K ﹤0.01%
618
+602
+3,763% +$26.2K
XMAX
3700
XMAX Inc
XMAX
$576M
$18.5K ﹤0.01%
4,908
+911
+23% +$2.04K
146 147
148
149 150

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.